CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Effects of Radiofrequency Ablation (RFA) in combination with Sorafenib in a 2-Tumor Rat Model of Hepatocellular Carcinoma
DOI 10.1055/s-0030-1269613
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Hora, JC Mertens, B Saar, J Kettenbach, M Ledermann, S Mertens, JF Dufour, A Geier
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Radiofrequency ablation (RFA) is a established therapy for hepatocellular carcinoma (HCC). Multitkinase inhibitor sorafenib prolongs survival in advanced HCC. We examined effects of RFA combined with sorafenib in a two-tumor rat model of HCC. Methods: 1mm cubes of Morris Hepatoma cells (MH) were were implanted into the right and left liver lobe of syngeneic ACI rats in four treatment groups. We administered so…
Zitieren
Zitierempfehlung
C Hora, JC Mertens, B Saar, J Kettenbach, M Ledermann, S Mertens, JF Dufour, A Geier (2011) Effects of Radiofrequency Ablation (RFA) in combination with Sorafenib in a 2-Tumor Rat Model of Hepatocellular Carcinoma. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0030-1269613
Mit CareLit weiterarbeiten